BMS Fends Off Teva Attack Over Blood Clot Patent
A Swedish judge has upheld a BMS patent for a blood clot treatment, concluding that the invention was new because it should be treated as having an earlier filing date under...To view the full article, register now.
Already a subscriber? Click here to view full article